Literature DB >> 24011306

Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK.

Morgana Rodrigues Guimarães1, Fábio Renato Manzoli Leite, Luís Carlos Spolidorio, Keith Lough Kirkwood, Carlos Rossa.   

Abstract

Curcumin is the active compound in the extract of Curcuma longa rhizomes with anti-inflammatory properties mediated by inhibition of intracellular signalling. SOCS and MAPKinases are involved in the signalling events controlling the expression of IL-6, TNF-α and PGE2, which have important roles on chronic inflammatory diseases. The aim was to assess if these pathways are involved in curcumin-mediated effects on LPS-induced expression of these cytokines in macrophages. RAW 264.7 murine macrophages were stimulated with Escherichia coli LPS in the presence and absence of non-cytotoxic concentrations of curcumin. Curcumin potently inhibited LPS-induced expression of IL-6, TNF-α and COX-2 mRNA and prevented LPS-induced inhibition of SOCS-1 and -3 expression and the inhibition of the activation of p38 MAPKinase by modulation of its nuclear translocation. In conclusion, curcumin potently inhibits expression of LPS-induced inflammatory cytokines in macrophages via mechanisms that involve modulation of expression and activity of SOCS-1 and SOCS-3 and of p38 MAPK.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell signalling; Curcumin; Cytokines; Innate immunity; MAPK; NF-kB; SOCS

Mesh:

Substances:

Year:  2013        PMID: 24011306      PMCID: PMC4030384          DOI: 10.1016/j.archoralbio.2013.07.005

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  46 in total

Review 1.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

Review 2.  Negative regulation of cytokine and TLR signalings by SOCS and others.

Authors:  Tetsuji Naka; Minoru Fujimoto; Hiroko Tsutsui; Akihiko Yoshimura
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

3.  Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer.

Authors:  Snehasikta Swarnakar; Krishnendu Ganguly; Parag Kundu; Aditi Banerjee; Pallab Maity; Anamika V Sharma
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

4.  Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets.

Authors:  Dong-Oh Moon; Cheng-Yun Jin; Jae-Dong Lee; Yung Hyun Choi; Soon-Cheol Ahn; Chang-Min Lee; Sang-Cheol Jeong; Yeong-Min Park; Gi-Young Kim
Journal:  Biol Pharm Bull       Date:  2006-07       Impact factor: 2.233

5.  The effect of turmeric extracts on inflammatory mediator production.

Authors:  R C Lantz; G J Chen; A M Solyom; S D Jolad; B N Timmermann
Journal:  Phytomedicine       Date:  2005-06       Impact factor: 5.340

6.  Curcumin therapy in inflammatory bowel disease: a pilot study.

Authors:  Peter R Holt; Seymour Katz; Robert Kirshoff
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

7.  Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study.

Authors:  Rafe Bundy; Ann F Walker; Richard W Middleton; Jonathan Booth
Journal:  J Altern Complement Med       Date:  2004-12       Impact factor: 2.579

8.  Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

Authors:  Hiroyuki Hanai; Takayuki Iida; Ken Takeuchi; Fumitoshi Watanabe; Yasuhiko Maruyama; Akira Andoh; Tomoyuki Tsujikawa; Yosihihide Fujiyama; Keiichi Mitsuyama; Michio Sata; Masami Yamada; Yasushi Iwaoka; Kazunari Kanke; Hideyuki Hiraishi; Kazuhisa Hirayama; Hajime Arai; Shigehito Yoshii; Masato Uchijima; Toshi Nagata; Yukio Koide
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11-13       Impact factor: 11.382

9.  Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.

Authors:  Mehdi Shakibaei; Thilo John; Gundula Schulze-Tanzil; Ingo Lehmann; Ali Mobasheri
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

10.  Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1.

Authors:  Ichiko Kinjyo; Hiromasa Inoue; Shinjiro Hamano; Satoru Fukuyama; Takeru Yoshimura; Keiko Koga; Hiromi Takaki; Kunisuke Himeno; Giichi Takaesu; Takashi Kobayashi; Akihiko Yoshimura
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

View more
  40 in total

1.  Effects of curcumin on Helicobacter pylori infection.

Authors:  Vaclav Vetvicka; Jana Vetvickova; Rafael Fernandez-Botran
Journal:  Ann Transl Med       Date:  2016-12

2.  Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.

Authors:  Li Xia; Yunlong Zhang; Tieli Dong
Journal:  J Mol Neurosci       Date:  2016-04-08       Impact factor: 3.444

Review 3.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

4.  Erratum to effects of curcumin on Helicobacter pylori infection.

Authors: 
Journal:  Ann Transl Med       Date:  2017-03

5.  Curcumin and capsaicin modulates LPS induced expression of COX-2, IL-6 and TGF-β in human peripheral blood mononuclear cells.

Authors:  Thriveni Vasanthkumar; Manjunatha Hanumanthappa; Rangaswamy Lakshminarayana
Journal:  Cytotechnology       Date:  2019-09-05       Impact factor: 2.058

6.  A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

Authors:  Muna S Elburki; Carlos Rossa; Morgana R Guimarães-Stabili; Hsi-Ming Lee; Fabiana A Curylofo-Zotti; Francis Johnson; Lorne M Golub
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 7.  Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.

Authors:  Shreena J Desai; Ben Prickril; Avraham Rasooly
Journal:  Nutr Cancer       Date:  2018-03-26       Impact factor: 2.900

8.  Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs.

Authors:  Huaping Zhang; Zhenxiang Zhao; Xuefen Pang; Jian Yang; Haixia Yu; Yinhong Zhang; Hui Zhou; Jiahui Zhao
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

9.  Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.

Authors:  Pragati P Nahar; Angela L Slitt; Navindra P Seeram
Journal:  J Med Food       Date:  2014-12-09       Impact factor: 2.786

Review 10.  Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis.

Authors:  Meysam Gachpazan; Sadra Habbibirad; Hoda Kashani; Tannaz Jamialahmadi; Hamid Reza Rahimi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.